Global Temperature-controlled Packaging for Pharmaceutical Market Research Report Forecast till 2023

$4,450$6,250

Clear

Description

The global temperature-controlled packaging for pharmaceutical market is driven by various factors, such as the growing pharmaceutical industry, the increase in R&D investment, and the adoption of smarter cold chain technology. Moreover, scope in Asia-Pacific is an opportunity for the growth of the market. However, rise in raw material costs restrains the market growth.
The global temperature-controlled packaging for pharmaceutical market is expected to grow at 9.48% CAGR during the forecast period. In 2017, the market was led by North America, with a 40.52% share, followed by Asia-Pacific, and Europe with shares of 26.90% and 21.59%, respectively.
The temperature-controlled packaging for pharmaceutical market has been segmented based on product, type, temperature range, payload capacity, type of use, end-use industry, and region. By product, the market has been segmented as insulated shippers and insulated containers. The insulated shippers segment accounted for the larger market share of 62.01% in 2017, with a market value of USD 3,172.3 million and is projected to register the highest CAGR of 9.26% during the forecast period. By type, active system segment accounted for the largest market share of 64.60% in 2017, with a market value of USD 3,304.7 million; projected to register the highest CAGR of 9.14% during the forecast period. By temperature range, the Up to 10°C segment accounted for the largest market share of 48.20% in 2017, with a market value of USD 2,466.1million; projected to witness the CAGR of 9.93% during the forecast period. Based on payload capacity, the Up to 10 L segment accounted for the market share of 30.11%, in 2017. On the other hand, among the type of use segments, single-use segment dominated the market, and accounted for market share of 81.71% in 2017. Pharmaceutical segment leads the market by end-use industry in 2017 with market value of USD 4,052.7 million, followed by clinical trials.

Table of Contents

Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Market Structure
2.4 List of Assumptions
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Research Methodology
4.1 Introduction
4.2 Drivers
4.2.1 Growth in the pharmaceutical industry
4.2.2 Adoption of smarter cold chain technology
4.2.3 Increase in R&D investment in the pharmaceutical industry
4.2.4 Drivers Impact Analysis
4.3 Restraint
4.3.1 Rise in raw material costs
4.3.2 Restraint Impact Analysis
4.4 Opportunity
4.4.1 Balanced clinical trial processes with an authentic data system
4.4.2 Government support
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Threat of New Entrants
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of Substitutes
5.1.5 Rivalry
5.2 Supply Chain Analysis
6 Global Temperature-controlled Packaging for Pharmaceutical Market, by Type
6.1 Overview
6.1.1 Active systems
6.1.2 Passive systems
7 Global Temperature-controlled Packaging for Pharmaceutical Market, by Product
7.1 Overview
7.1.1 Insulated Shippers
7.1.2 Insulated Containers
8 Global Temperature-controlled Packaging for Pharmaceutical Market, by Temperature Range
8.1 Overview
8.1.1 Less than -20°C
8.1.2 2°C to 8°C
8.1.3 15°C to 25°C
9 Global Temperature-controlled Packaging for Pharmaceutical Market, by Payload Capacity
9.1 Overview
9.1.1 Payload Capacity
10 Global Temperature-controlled Packaging for Pharmaceutical Market, by Type of use
10.1 Overview
10.1.1 Single Use
10.1.2 Re-usable
11 Global Temperature-controlled Packaging for Pharmaceutical Market, by End-use Industry
11.1 Overview
11.1.1 Pharmaceutical
11.1.2 Clinical Trials
12 Global Temperature-controlled Packaging for Pharmaceutical Market, by Region
12.1 North America
12.1.1 U.S.
12.1.2 Canada
12.2 Europe
12.2.1 Germany
12.2.2 U.K
12.2.3 France
12.2.4 Spain
12.2.5 Italy
12.2.6 Rest of Europe
12.3 Asia-Pacific
12.3.1 China
12.3.2 Japan
12.3.3 South Korea
12.3.4 Taiwan
12.3.5 Philippines
12.3.6 Indonesia
12.3.7 Thailand
12.3.8 Malaysia
12.3.9 Singapore
12.3.10 Hong Kong
12.3.11 Australia
12.3.12 Rest of Asia Pacific
12.4 Rest of the World (RoW)
12.4.1 Middle East & Africa
12.4.2 Latin America
13 Competitive Landscape
13.1 Competitive Landscape
13.2 Market Share Analysis
13.3 Competitors Benchmarking
14 Company Profiles
14.1 Cold Chain Technologies
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products/Service Offered
14.1.4 Key Developments (2014–2018)
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Envirotainer AB
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products/Services Offered
14.2.4 Key Developments, (2015-2018)
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Pelican BioThermal
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products/Services Offered
14.3.4 Key Developments (2015-2018)
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 Sofrigam
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products/Services Offered
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Softbox Systems Limited
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products/Service Offered
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 Sonoco ThermoSafe
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products Offered
14.6.4 Key Developments (2015-2018)
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 Storopack Hans Reichenecker GmbH
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offered
14.7.4 Key Developments (2015-2018)
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 va-Q-tec AG
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products/Services Offered
14.8.4 Key Developments (2015-2018)
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 DB Schenker
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products/Services Offered
14.9.4 Key Developments (2014–2018)
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 DHL International GmbH
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products/Service Offered
14.10.4 Key Developments (2014-2018)
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 KUEHNE + NAGEL INC
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products/Services Offered
14.11.4 Key Developments (2014–2018)
14.11.5 SWOT Analysis
14.11.6 Key Strategy
14.12 United Parcel Service of America, Inc. (UPS)
14.12.1 Company Overview
14.12.2 Financial Overview
14.12.3 Products/Services Offered
14.12.4 Key Developments (2014–2018)
14.12.5 SWOT Analysis
14.12.6 Key Strategy

Additional information

Publisher

Geography Covered

Date Published

Pages

Format